Peripheral Intravenous Catheters Market Size, Share, Growth, and Industry Analysis, By Types (Short Peripheral I.V. Catheter, Integrated/Closed Peripheral I.V. Catheter, ), By Applications (Renal Disease, Oncology, Pediatric Disease, Gastroenterology, Infectious Disease, ) , and Regional Insights and Forecast to 2035

Peripheral Intravenous Catheters Market Size

Global Peripheral Intravenous Catheters Market size was USD 5.2 billion in 2025 and is projected to touch USD 5.52 billion in 2026, USD 5.86 billion in 2027 to USD 9.44 billion by 2035, exhibiting a 6.13 % during the forecast period [2026-2035]. The market is growing due to increasing hospital admissions, rising chronic disease cases, and growing use of intravenous therapies. More than 68% of hospitalized patients require peripheral intravenous access for medicine delivery and hydration therapy. Around 52% of healthcare facilities are adopting advanced safety catheter systems to reduce infection and contamination risks during treatment procedures.

The US Peripheral Intravenous Catheters Market is witnessing steady growth because of increasing emergency care procedures and strong healthcare infrastructure. More than 63% of hospitals in the country use integrated catheter systems for infection prevention and patient safety. Around 47% of healthcare providers are focusing on advanced blood-control catheter technologies to improve treatment efficiency. Home healthcare and outpatient intravenous therapies have increased by nearly 39%, supporting strong demand for peripheral intravenous catheters across clinics, hospitals, and long-term care facilities.

Key Findings

• Market Size: Global Peripheral Intravenous Catheters Market reached USD 5.2 billion in 2025, USD 5.52 billion in 2026, and USD 9.44 billion by 2035 at 6.13 % growth.
• Growth Drivers: Over 68% hospital patients require intravenous therapy, while 52% healthcare facilities increased adoption of safety catheter technologies and infection prevention systems.
• Trends: Around 47% hospitals shifted toward integrated catheter systems, while 41% healthcare centers adopted antimicrobial-coated and closed intravenous catheter technologies.
• Key Players: Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Smiths Medical, Inc. & more.
• Regional Insights: North America holds 38% market share, Europe 29%, Asia-Pacific 24%, and Middle East & Africa 9% supported by healthcare expansion.
• Challenges: Nearly 35% catheter complications and 31% device failure rates increased operational pressure, while 33% healthcare facilities reported skilled staff shortages.
• Industry Impact: More than 54% healthcare centers improved patient safety standards, while 46% increased focus on infection prevention and treatment efficiency.
• Recent Developments: Around 45% new catheter products included safety technologies, while 38% manufacturers introduced antimicrobial-coated and blood-control catheter systems.

Peripheral intravenous catheters are becoming important in modern healthcare because they support rapid medicine delivery, hydration therapy, and emergency treatment procedures. More than 72% of inpatient treatments involve peripheral intravenous access systems. Healthcare facilities are increasingly adopting integrated catheter products due to nearly 41% lower contamination risks and improved patient comfort. Pediatric and elderly patient care applications are also expanding because over 36% of hospitals are focusing on flexible and pain-reduction catheter technologies. The market is also benefiting from rising outpatient treatment services and increasing preference for home-based intravenous therapies across healthcare systems.

Peripheral Intravenous Catheters Market Trends

The Peripheral Intravenous Catheters Market is showing strong growth due to the increasing number of hospital admissions, rising chronic disease cases, and higher demand for safe drug delivery systems. More than 65% of hospitalized patients require peripheral intravenous access during treatment, making peripheral intravenous catheters an important medical device across healthcare facilities. Around 58% of emergency care procedures depend on peripheral intravenous catheters for quick fluid and medication administration. The use of safety-engineered catheters has increased by nearly 47% because hospitals are focusing on reducing needle-stick injuries and infection risks.

Short peripheral intravenous catheters account for over 72% of total product usage because they are widely used for blood collection, hydration therapy, and medicine infusion. Integrated catheter systems have witnessed adoption growth of nearly 41% due to better patient comfort and reduced catheter failure rates. In addition, over 54% of healthcare centers are shifting toward closed catheter systems to lower contamination risks. The elderly population contributes to more than 49% of catheter demand because aging patients often require long-term treatments and repeated vascular access procedures.

North America holds a major share in the Peripheral Intravenous Catheters Market due to advanced healthcare infrastructure and strong adoption of infection prevention technologies. Asia-Pacific is witnessing rapid growth with more than 43% increase in hospital infrastructure development activities. Around 52% of healthcare professionals now prefer catheters with antimicrobial coatings for better patient safety. Portable healthcare services and home-based treatments have also increased catheter demand by nearly 38%, especially among patients receiving long-term therapies and post-surgical care.

Peripheral Intravenous Catheters Market Dynamics

OPPORTUNITY

"Growing Demand for Home Healthcare and Outpatient Services"

The growing preference for home healthcare services is creating major opportunities in the Peripheral Intravenous Catheters Market. Nearly 46% of patients receiving long-term therapy now prefer treatment outside traditional hospital settings. Home infusion therapy usage has increased by more than 39%, leading to stronger demand for easy-to-use peripheral intravenous catheters. Around 51% of outpatient centers are adopting advanced catheter systems with safety features to improve patient care quality. In addition, over 44% of healthcare providers are focusing on portable and infection-resistant catheter devices to support home-based treatments and reduce hospital overcrowding.

DRIVERS

"Rising Demand for Emergency and Critical Care Treatments"

The increasing number of emergency cases and critical care procedures is driving the Peripheral Intravenous Catheters Market. More than 68% of emergency room patients require immediate intravenous access for medication and fluid administration. The demand for rapid vascular access devices has grown by nearly 42% across intensive care units. Around 57% of healthcare facilities are now using advanced catheter stabilization technologies to reduce catheter dislodgement and improve treatment efficiency. In addition, over 48% of surgical procedures depend on peripheral intravenous catheters for anesthesia delivery and patient monitoring during operations.

RESTRAINTS

"High Risk of Catheter-Related Complications"

The Peripheral Intravenous Catheters Market faces restraints due to complications linked with catheter usage. Nearly 35% of patients experience issues such as phlebitis, infiltration, or catheter blockage during intravenous therapy. Around 29% of healthcare workers report concerns related to infection risks from improper catheter placement and maintenance. Catheter failure rates exceed 31% in some healthcare settings, leading to repeated insertion procedures and patient discomfort. In addition, almost 27% of hospitals face increased operational pressure due to additional monitoring and replacement requirements associated with peripheral intravenous catheters.

CHALLENGE

"Rising Costs and Shortage of Skilled Healthcare Professionals"

The Peripheral Intravenous Catheters Market is facing challenges because of increasing healthcare costs and the shortage of trained medical professionals. More than 33% of healthcare centers report difficulties in maintaining skilled staff for accurate catheter insertion and monitoring. Around 37% of catheter-related failures are linked to improper handling techniques and lack of training. Healthcare facilities are also witnessing nearly 28% growth in operational burden due to strict infection prevention protocols and device management requirements. In addition, over 32% of smaller healthcare providers struggle to adopt advanced catheter technologies because of higher device handling and training expenses.

Segmentation Analysis

The Peripheral Intravenous Catheters Market is segmented by type and application based on patient treatment needs, hospital usage, and healthcare procedure volume. Global Peripheral Intravenous Catheters Market size was USD 5.2 Billion in 2025 and is projected to touch USD 5.52 Billion in 2026 to USD 9.44 Billion by 2035, exhibiting a CAGR of 6.13 % during the forecast period [2025-2035]. Short Peripheral I.V. Catheter products account for a major portion of total product demand because more than 69% of hospital-based intravenous therapies use short-term catheter access systems. Integrated and closed catheter systems are witnessing fast adoption due to nearly 48% lower contamination risks and improved patient safety rates. By application, oncology and renal disease segments contribute strongly because over 57% of chronic care patients require repeated intravenous medication administration. Pediatric disease applications are also growing steadily due to nearly 36% increase in child hospitalization and emergency care procedures.

By Type

Short Peripheral I.V. Catheter

Short Peripheral I.V. Catheters are widely used in hospitals, clinics, and emergency care centers because they provide quick vascular access for medicine delivery and fluid administration. More than 72% of inpatient procedures involve short peripheral catheter use. Around 46% of healthcare providers prefer these devices because of easy insertion and lower treatment delays. Infection control improvements and safety stabilization technologies have increased adoption by nearly 39%. These catheters are commonly used in surgical care, trauma treatment, and hydration therapy across healthcare facilities.

Short Peripheral I.V. Catheter segment held the largest share in the Peripheral Intravenous Catheters Market, accounting for USD 3.38 Billion in 2025, representing 65% of the total market. This segment is expected to grow at a CAGR of 6.0% from 2025 to 2035, driven by rising hospital admissions, emergency procedures, and increasing intravenous therapy demand.

Integrated/Closed Peripheral I.V. Catheter

Integrated and closed Peripheral I.V. Catheters are gaining strong demand because healthcare facilities are focusing on infection prevention and patient safety. Nearly 52% of advanced hospitals now use integrated catheter systems to reduce blood exposure and contamination risks. Around 41% reduction in catheter-related complications has been reported with closed systems. Demand has increased by more than 44% due to rising awareness regarding needle-stick injury prevention among healthcare workers. These catheters are also preferred for long-duration therapies and intensive care treatments.

Integrated/Closed Peripheral I.V. Catheter segment accounted for USD 1.82 Billion in 2025, representing 35% of the total market. This segment is expected to grow at a CAGR of 6.4% from 2025 to 2035, supported by increasing infection control practices and strong adoption of safety-engineered catheter systems.

By Application

Renal Disease

Peripheral intravenous catheters are highly used in renal disease treatment due to repeated fluid therapy and medication administration requirements. More than 43% of dialysis-related support procedures require peripheral intravenous access. Around 38% of renal patients receive frequent intravenous treatments during hospitalization. Healthcare providers are increasing catheter usage because nearly 34% of kidney disease patients require emergency vascular access support during treatment procedures and post-treatment care.

Renal Disease segment accounted for USD 1.14 Billion in 2025, representing 22% of the total market. This segment is expected to grow at a CAGR of 5.9% from 2025 to 2035 due to increasing chronic kidney disease cases and rising dialysis procedures.

Oncology

Oncology applications represent a major share in the Peripheral Intravenous Catheters Market because cancer patients require continuous intravenous drug administration. More than 58% of chemotherapy procedures depend on peripheral intravenous catheter systems. Around 47% of oncology care centers are using advanced catheter stabilization systems for safe medication delivery. Increasing cancer screening and treatment procedures are supporting higher catheter demand across hospitals and specialty care centers.

Oncology segment accounted for USD 1.35 Billion in 2025, representing 26% of the total market. This segment is expected to grow at a CAGR of 6.5% from 2025 to 2035 due to growing chemotherapy procedures and supportive care treatments.

Pediatric Disease

Pediatric disease applications are increasing due to growing child hospitalization and vaccination support programs. Nearly 36% of pediatric emergency cases require immediate intravenous access for fluid and medicine administration. Around 32% of healthcare providers prefer smaller safety catheter systems for neonatal and child care. Hospitals are focusing on pain reduction technologies, which has increased pediatric catheter usage by nearly 28%.

Pediatric Disease segment accounted for USD 0.88 Billion in 2025, representing 17% of the total market. This segment is expected to grow at a CAGR of 6.1% from 2025 to 2035 because of increasing pediatric healthcare services and emergency treatments.

Gastroenterology

Peripheral intravenous catheters are widely used in gastroenterology treatments for nutrition support, hydration therapy, and medicine infusion. More than 33% of digestive disease patients require intravenous fluid management during treatment procedures. Around 29% increase in gastrointestinal surgeries has supported higher catheter demand. Hospitals are also using advanced catheter systems to improve treatment speed and reduce procedural complications during digestive care therapies.

Gastroenterology segment accounted for USD 0.78 Billion in 2025, representing 15% of the total market. This segment is expected to grow at a CAGR of 5.8% from 2025 to 2035 due to increasing digestive disease treatments and surgical procedures.

Infectious Disease

Infectious disease treatment requires continuous intravenous medication support, increasing the use of peripheral intravenous catheters. Nearly 49% of severe infection treatment procedures involve intravenous antibiotic administration. Around 37% of intensive care patients with infections require repeated vascular access support. Healthcare facilities are increasing demand for antimicrobial-coated catheter systems to reduce contamination risks and improve patient safety during infectious disease management.

Infectious Disease segment accounted for USD 1.05 Billion in 2025, representing 20% of the total market. This segment is expected to grow at a CAGR of 6.2% from 2025 to 2035 driven by increasing hospitalization for infectious disease management and intravenous antibiotic therapies.

Peripheral Intravenous Catheters Market Regional Outlook

Global Peripheral Intravenous Catheters Market size was USD 5.2 Billion in 2025 and is projected to touch USD 5.52 Billion in 2026 to USD 9.44 Billion by 2035, exhibiting a CAGR of 6.13 % during the forecast period [2026-2035]. Regional growth is supported by increasing hospital admissions, rising chronic disease cases, and expansion of healthcare infrastructure. North America holds 38% market share due to advanced healthcare systems and strong use of safety catheter devices. Europe accounts for 29% share because of growing infection prevention programs and increasing surgical procedures. Asia-Pacific represents 24% share due to rising healthcare spending and expanding hospital infrastructure. Middle East & Africa contributes 9% share supported by improving healthcare access and growing emergency care services.

North America

North America continues to show strong demand for peripheral intravenous catheters because more than 71% of hospital procedures require intravenous access support. Around 63% of healthcare facilities in the region have adopted integrated catheter systems to reduce infection and needle-stick injury risks. Emergency care procedures have increased by nearly 34%, supporting higher demand for rapid vascular access devices. Home healthcare services are also expanding, with over 41% growth in outpatient intravenous therapy treatments. The region benefits from advanced healthcare technologies and strong awareness regarding patient safety and infection prevention protocols.

North America accounted for USD 2.10 Billion in 2026, representing 38% of the total market share. Growth in this region is supported by increasing chronic disease treatment procedures, strong healthcare infrastructure, and rising use of advanced catheter stabilization systems.

Europe

Europe is witnessing stable growth in the Peripheral Intravenous Catheters Market due to increasing hospital admissions and rising elderly population. Nearly 57% of hospitals across the region are using safety-engineered intravenous catheter systems. Around 46% of healthcare providers focus on reducing catheter-related bloodstream infections through advanced closed systems. Surgical procedures have increased by nearly 31%, supporting strong demand for intravenous access devices. In addition, over 39% of outpatient treatment centers are expanding intravenous therapy services for long-term disease management and supportive care treatments.

Europe accounted for USD 1.60 Billion in 2026, representing 29% of the total market share. Regional growth is driven by strong healthcare regulations, increasing patient safety awareness, and rising demand for minimally invasive treatment support systems.

Asia-Pacific

Asia-Pacific is experiencing rapid growth in the Peripheral Intravenous Catheters Market because of increasing healthcare investments and expanding patient population. More than 52% of regional healthcare infrastructure projects focus on hospital modernization and emergency care development. Around 44% increase in chronic disease treatment procedures has raised demand for intravenous therapy devices. Healthcare access improvements and rising medical tourism activities are also supporting catheter demand across hospitals and specialty care centers. In addition, over 37% of healthcare facilities are adopting advanced catheter systems for infection prevention and better treatment efficiency.

Asia-Pacific accounted for USD 1.32 Billion in 2026, representing 24% of the total market share. Growth is supported by increasing hospital expansion activities, rising healthcare awareness, and higher demand for emergency and critical care services.

Middle East & Africa

Middle East & Africa is showing gradual growth in the Peripheral Intravenous Catheters Market due to improving healthcare infrastructure and increasing emergency care requirements. Nearly 33% of hospitals in the region are investing in infection prevention technologies and safety catheter systems. Around 29% increase in chronic disease cases has raised demand for intravenous medication administration. Government healthcare improvement programs and growing medical facility development are supporting catheter adoption across urban healthcare centers. In addition, over 26% of healthcare providers are increasing focus on patient safety training and vascular access management practices.

Middle East & Africa accounted for USD 0.50 Billion in 2026, representing 9% of the total market share. Regional demand is supported by rising healthcare modernization projects, improving access to medical services, and increasing emergency treatment procedures.

List of Key Peripheral Intravenous Catheters Market Companies Profiled

Investment Analysis and Opportunities in Peripheral Intravenous Catheters Market

Investment activities in the Peripheral Intravenous Catheters Market are increasing because healthcare providers are focusing on infection prevention, patient safety, and advanced vascular access technologies. More than 48% of medical device investors are supporting development of integrated catheter systems with safety mechanisms. Around 42% of hospitals are increasing spending on advanced intravenous access devices to reduce catheter-related complications. Demand for antimicrobial-coated catheters has increased by nearly 37%, creating strong opportunities for manufacturers and healthcare suppliers. In addition, over 33% of healthcare infrastructure projects include investments in emergency care and outpatient treatment facilities, supporting future catheter demand. Home healthcare services are also creating investment opportunities because nearly 39% of patients now prefer outpatient intravenous therapies. Companies are expanding manufacturing facilities and strengthening distribution networks to improve supply chain efficiency and product accessibility across developing healthcare markets.

New Products Development

Manufacturers in the Peripheral Intravenous Catheters Market are focusing on new product development to improve patient comfort, reduce infections, and increase device efficiency. More than 45% of newly launched catheter products include integrated safety mechanisms to lower needle-stick injuries. Around 38% of new devices feature antimicrobial coatings for better infection prevention during long-term intravenous therapies. Healthcare providers are showing nearly 34% higher preference for closed catheter systems with blood control technology. In addition, companies are developing smaller and flexible catheter products for pediatric and elderly patient care. More than 29% of research activities are focused on reducing catheter insertion pain and improving stabilization systems. Portable infusion compatibility and easy-to-use catheter designs are also gaining strong demand among home healthcare providers and outpatient treatment centers.

Developments

• Becton, Dickinson and Company: Expanded its safety catheter portfolio with improved blood control technology to reduce contamination exposure. The updated device design improved insertion efficiency by nearly 32% and supported better healthcare worker safety during emergency treatments.
• B. Braun Melsungen AG: Introduced advanced integrated peripheral intravenous catheter systems with enhanced stabilization features. The company reported nearly 28% improvement in catheter securement performance and stronger adoption across intensive care and surgical departments.
• Terumo Corporation: Developed flexible catheter products focused on patient comfort and lower vein irritation. Clinical usage studies showed around 26% reduction in catheter-related complications during prolonged intravenous therapy procedures.
• Teleflex Incorporated: Increased production capacity for safety-engineered intravenous catheters to support growing hospital demand. The expansion improved product supply efficiency by nearly 31% across emergency care and outpatient treatment facilities.
• Smiths Medical, Inc.: Launched advanced infection-resistant catheter technology with improved fluid management features. Healthcare providers observed approximately 24% better treatment efficiency and lower catheter replacement frequency during clinical procedures.

Report Coverage

The Peripheral Intravenous Catheters Market report provides detailed analysis of market trends, growth drivers, restraints, challenges, opportunities, segmentation, regional outlook, and competitive landscape. The report studies major healthcare sectors including emergency care, oncology, renal disease treatment, pediatric care, gastroenterology, and infectious disease management. More than 68% of healthcare procedures involving intravenous therapy are analyzed to understand changing catheter demand patterns. The report also examines technological developments such as integrated catheter systems, antimicrobial coatings, and blood control technologies that improve patient safety and reduce contamination risks.

The SWOT analysis within the report highlights major strengths including growing healthcare infrastructure, increasing chronic disease treatment procedures, and rising adoption of safety catheter systems. Nearly 57% of healthcare providers now focus on infection prevention technologies, supporting strong market growth. Weakness factors include catheter-related complications, product replacement issues, and shortage of skilled healthcare professionals. Around 35% of healthcare facilities continue facing challenges related to improper catheter insertion and maintenance procedures.

The report also evaluates opportunities linked with home healthcare expansion, outpatient treatment growth, and rising investment in emergency care infrastructure. More than 41% increase in home-based intravenous therapies has created strong demand for easy-to-use catheter systems. Threat analysis covers strict regulatory requirements, product recalls, and increasing competition among manufacturers. Around 29% of smaller healthcare facilities face operational challenges because of advanced device handling and training requirements. The report further studies product innovation strategies, distribution network expansion, and regional healthcare development activities shaping the future of the Peripheral Intravenous Catheters Market.

Future Scope

The future scope of the Peripheral Intravenous Catheters Market remains strong due to increasing healthcare demand, rising chronic disease cases, and growing need for safe intravenous treatment systems. More than 62% of healthcare providers are expected to increase adoption of integrated catheter technologies to improve patient safety and reduce infection risks. Hospitals and outpatient care centers are focusing on advanced vascular access systems with nearly 44% higher preference for closed and blood-control catheter products. Increasing elderly population and rising hospitalization rates are expected to support continuous demand for peripheral intravenous catheters across healthcare facilities.

Technological innovation will play an important role in future market growth. Nearly 39% of manufacturers are investing in antimicrobial coatings and flexible catheter materials to improve patient comfort and treatment efficiency. Artificial intelligence-supported vascular access technologies and smart monitoring systems are also expected to gain attention in advanced healthcare facilities. Around 34% of healthcare institutions are increasing digital monitoring adoption for intravenous therapy management and patient tracking systems.

Home healthcare and outpatient treatment services will continue creating strong growth opportunities for the Peripheral Intravenous Catheters Market. More than 43% of patients are expected to prefer home-based infusion therapies because of convenience and lower hospital dependency. Pediatric and oncology treatment applications are also projected to expand steadily due to increasing specialized care procedures. In addition, healthcare infrastructure development activities in emerging economies are expected to improve product accessibility and increase catheter usage across regional healthcare systems. Continuous focus on infection prevention, patient comfort, and advanced safety technologies will support long-term market expansion.